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Abstract Recent advances in nanomaterials science con-
tributed to develop new micro- and nano-devices as
potential diagnostic and therapeutic tools in the field of
oncology. The synthesis of superparamagnetic nanoparti-
cles (SPMNPs) has been intensively studied, and the use of
these particles in magnetic hyperthermia therapy has
demonstrated successes in treatment of cancer. However,
some physical limitations have been found to impact the
heating efficiency required to kill cancer cells. Moreover,
the bio-safety of NPs remains largely unexplored. The
primary goals of this review are to summarize the recent
progress in the development of magnetic nanoparticles
(MNPs) for hyperthermia, and discuss the limitations and
advances in the synthesis of these particles. Based on this
knowledge, new perspectives on development of new
biocompatible and biofunctional nanomaterials for mag-
netic hyperthermia are discussed.
Keywords Magnetic nanoparticles  Synthesis  Magnetic
hyperthermia  Cancer
Introduction
According to the National Cancer Institute, cancer is cur-
rently the second leading cause of death in the United
States, exceeded only by heart disease as the number one
killer. A total of 1,620 Americans are expected to die of
cancer per day in 2015.
Significant progress has been made so far in nanotech-
nology for the diagnosis and treatment of cancer. A variety
of magnetic nanomaterials has been developed to achieve
improved efficacy in cancer therapy as well as reduced side
effects compared to conventional therapies. The interest in
MNPs is due to their unique magnetic properties; they
exhibit diagnostic tool, drug carrier and heat generator for
therapy in magnetic resonance imaging (MRI), so-called
‘theranostic’ and their small sizes, which allow the parti-
cles to reach most biological tissues. Currently, iron oxide
nanoparticles (IONPs) are the most explored MNPs for
magnetic hyperthermia, because of their lack of toxicity
and their known pathways of metabolism (Tran et al.
2012a, b).
The generation of heat by the exposition of MNPs to a
non-invasive alternating magnetic field (AMF) can be used
to destroy tumor tissue, given that heat promotes cell
apoptosis through irreversible physiological changes (Pra-
sad et al. 2007). This approach is known as magnetic
hyperthermia. The basics of the magnetic properties
required in MNPs for magnetic hyperthermia applications
will be discussed later in detail.
The synthesis methods of MNPs have an impressive
impact on the magnetic and morphological properties of
the final product (Castellanos-Rubio et al. 2015). There-
fore, a synthesis method with the ability to rigorously
control the composition, size and shape is needed. This
paper presents a short review on the current methods for
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synthesis of MNPs for nanomedicine, and discusses
important findings reported earlier.
Basics of magnetism in magnetic hyperthermia
An understanding of the relationship between physico-
chemical properties (for example: structure, particle size)
and magnetic properties is essential to design new mag-
netic materials for magnetic hyperthermia applications.
Therefore, a review on the basic concepts in nano-mag-
netism will be discussed shortly.
Soft and hard magnets
When a ferromagnetic material, such as Iron, nickel and
cobalt, is placed in a magnetic field of strength ‘H’, the
atoms acquire an induced magnetic moment ‘m’ randomly
oriented. The magnetic moments pointed in the same
direction per volume of atoms are called magnetization
‘M’. The magnetic induction ‘B’ is given by Maxwell’s
equation (Eq. 1) (Laurent et al. 2011).
B ¼ l0 H þMð Þ ð1Þ
where l0 is the permeability of the free space which equals
to 4p 107 V.s/A.m.
The small regions of magnetization are called magnetic
domains, and the boundaries between domains are called
domain walls. In the absence of an external magnetic field,
ferromagnetic material does not show any magnetization
due to the random orientation of the magnetizations in
magnetic domains (Point a, Fig. 1). However, when an
external magnetic field is applied, magnetic moments
become aligned to the direction of the magnetic field, so
the domain walls disappear and the magnetization becomes
saturated, the so-called saturation magnetization (Ms)
(Fig. 1).
Once the applied magnetic field is removed, ferromag-
netic materials keep some memory of the applied field
(Point b, Fig. 1), called remanence (Mr). A coercive force
must be applied to reduce the remanent magnetization to
zero and close the loop.
Ferromagnetic materials can be categorized into soft and
hard magnets (Mody et al. 2013). Soft magnets have a low
coercivity (Hc), so they can be demagnetized at low
magnetic field. However, hard magnets exhibit a high Hc
and thus they are difficult to demagnetize.
Multi-domain to single domain
The magnetostatic (dipole–dipole) energy is inversely
proportional to the volume of the particle (r3), and the
domain-wall energy is proportional to the area of the wall
(r2) (Fig. 2) (Spaldin 2011).
By looking at the balance between the magnetostatic
energy and the domain wall energy, it is energetically
unfavorable to form domain walls below a critical radius,
because the domain-wall energy is very low, and a single
domain is formed as a result of high magnetostatic energy.
For a sphere containing two semi-sphere domains of
opposite magnetization with axial magnetic anisotropy, the








Fig. 1 Typical hysteresis loop of ferromagnetic materials (adapted
from Mody et al. 2013)
Fig. 2 Relative stability of multi-domain and single domain (adapted
from Spaldin 2011)
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where A is the exchange stiffness and K1 is the first uniaxial
anisotropy constant.
The critical radius values corresponding to ferromag-
netic elements Fe, Co and Ni are calculated according to
Eq. (2) and are presented in Table 1.
Superparamagnetism
It has been found that with a further decrease in particle
size below the critical radius, the coercivity Hc decreases
significantly to reach zero. When the coercivity becomes
zero, the particles magnetize in the presence of an external
magnetic field and revert to a non-magnetic state when the
external magnetic field is removed (Fig. 3) (Mody et al.
2013).
This behavior can be explained by the fact that a small
magnetic particle less than critical size prefers to be uni-
formly magnetized along one of its easy axes (h = 0,
h = p), and the energy required to rotate the magnetization
away from the easy direction is called magnetic anisotropy
energy. In a simple model for a non-interacting single-
domain spherical particle with uniaxial anisotropy in zero
magnetic field, the magnetic anisotropy energy ‘EA’ is
given by an expression of Eq. (3) (Stoner and Wohlfarth
1948).
EA ¼ K  V  sin2 h ð3Þ
where K is the anisotropy constant, V is the volume of the
particle and h is the angle between the particle magneti-
zation and the easy magnetization axis of the particle.
According to Eq. (3), the magnetic anisotropy energy
decreases when the volume of the particle becomes smal-
ler. Furthermore, the anisotropy energy becomes compa-
rable to or even lower than the thermal energy
(Ethermal = kBT, where kB is Boltzmann constant) (Krish-
nan 2010). As a result, the energy barrier for magnetization
reversal can be overcome thermally (Fig. 4). This phe-
nomenon is called ‘superparamagnetism’.
Due to the fact that these particles are magnetically
controlled by an external magnetic field and maintain a
colloidal stability upon removal of the external magnetic
field, superparamagnetic particles have a unique advantage
for biomedical applications.
For spherical magnetic particles, the transition from
single domain to superparamagnetic ‘r0’ depends on the
size and/or geometry of the particles and can be determined
by the following Eq. (4) (Martel 2015):




where TB is the blocking temperature.
Table 2 provides calculated values of the transition
radius ‘r0’, according to Eq. (4), for the main magnetic
nanomaterials (Martel 2015; Kolhatkar et al. 2013).
Although particle moves toward superparamagnetism
when the size of the particle decreases below the transition
point and becomes suitable for biomedical application, the
saturation magnetization ‘Ms’ reduces. The magnitude of
Table 1 Magnetic parameters at room temperature (Skomski 2003)
Ferromagnetic particles Fe Co Ni
A (pJ/m) 8.3 10.3 3.4
K1 (MJ/m3) 0.05 0.53 -0.005
l0Ms (T) 2.15 1.76 0.61
rC (nm) 6 34 16
Fig. 3 The magnetic response characteristic of a superparamagnetic
material (adapted from Mody et al. 2013)
Fig. 4 Schematic of anisotropy energy barrier for magnetization
reversal (adapted from Stoner and Wohlfarth 1948)
Prog Biomater (2016) 5:147–160 149
123
Ms is inversely proportional to the ratio of disordered spin
layer at the surface to the radius of the particle, which
significantly increases when the size of the nanoparticle
becomes too small. The relationship between Ms, the size
and the disordered spin layer is described by Eq. (5) (Jun
et al. 2008):




where d is the thickness of the particle’s surface exhibiting
disordered spins, and Msb is the bulk Ms. Recent studies on
the effect of the size of MNPs upon its saturation magne-
tization are summarized in Table 3. According to the
studies listed in Table 3, the Ms increases with the size of
the MNPs due to the reduction of the spin disorder effect.
Recent study done by Guardia et al. have demonstrated
that the surface coating of iron oxide (Fe3O4) NPs with
oleic acid increases their measured Ms to reach the bulk
value, by reducing the level of surface spin disorder
(Guardia et al. 2007).
Heat generation
Heating tumor cells with SPMNPs by magnetic hyper-
thermia is based on Neel and Brownian relaxations. In the
presence of an external alternating magnetic field, the
magnetic moment rotates and the nanoparticle itself
rotates, then relaxes back to their original magnetic field
orientation. The rotation of the magnetic moment (Neel
mode) and the friction arising from particle oscillations
(Brownian mode) leads to a phase lag between applied
magnetic field and the direction of the magnetic moments.
As a result, the heat is released.
The efficiency of heating is measured in terms of the
specific absorption rate (SAR), or specific loss of power
(SLP), which is defined in Eq. (6). For biomedical appli-
cations, the value of SAR is crucial, because the higher the
specific absorption rate, the lower the injected dose to the
patient.
SAR or SLP W=gð Þ ¼ CDT
Dt
ð6Þ
where C is the specific heat capacity of water, and DT/Dt is
the rate of change of temperature versus time.
According to Rosensweig (2002), there is a strong
relationship between the SAR of SPMNPs and its magnetic











the magnetic volume for a particle of radius r, H0 is the
magnetic field intensity, m is the frequency of the oscillat-
ing magnetic field and s is the relaxation time. The other
parameters (lo is the permeability of the free space), p,
k (Boltzmann constant) and T (temperature of the sample)
have their classical meanings.
Also, Eq. (7) shows that the SAR strongly depends on
the Ms and the volume fraction of the SPMNPs. Not only
high Ms values are required for thermal energy dissipation
in the tumor cells, but also to give more control on the
magnetophoretic velocity of the MNPs ‘Vmag’ in the blood
using external magnetic field (Grief and Richardson 2005)
(Eq. 8).
Vmag ¼ Ms  Vmicrodevice  rB
6  p  Rmicrodevice  l ð8Þ
where Vmicrodevice is the volume of microdevice (m
3), rB is
the magnetic gradient applied (T/m), Rmicrodevice is the
microdevice radius (m) and l is the blood viscosity (Pa.s).
Theoretically, a critical diameter dc is defined as the
diameter for which the Neel relaxation time ‘sN’ (Eq. 9) is
equal to the Brownian relaxation time ‘sB’ (Shliomis and
Stepanov 1990) (Eq. 10). For small particles with a
diameter\dc, Neel relaxation is predominant. However,
the heating is primarily due to Brownian rotation in larger
particles with a diameter[dc. The dominating contribution




Table 2 Maximum radius for superparamagnetic NPs of different compositions (Martel 2015; Kolhatkar et al. 2013)
Superparamagnetic NPs Co CoPt Co Fe2O4 FeCo Fe3O4 Fe2O3 FePt Ni
r0 (nm) 5 1 5 10 12.5 15 1.5 15
Table 3 Magnetizations of a variety of types of MNPs of varying
sizes
MNPs Size (nm) Ms (emu/g) References





Ni 24 25.3 He and Shi (2012)
50 32.3
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sB ¼ 3gVB
kB  T ð10Þ
where K is the anisotropy constant of magnetite which is
over the range of 23,000–100,000 J m-3, while
s0 & 109–1012 s is the relaxation time of non-interact-
ing MNPs, g is the viscosity of the surrounding liquid and
VB is the hydrodynamic volume of the particle; kB is the
Boltzmann constant and T is the temperature of the sample.
The frequency mN for maximal heating via Neel relax-
ation is given by Eq. (11), and the frequency mB for max-
imal heating via Brown rotation is given by Eq. (12)
(Fannin and Charles 1991).
2pmNsN ¼ 1 ð11Þ
2pmBsB ¼ 1 ð12Þ
When the diameter of the particle is close to dc,
sN & sB and an effective relaxation time ‘seff’ is defined in
Eq. (13). The frequency for maximal heating ‘meff’ is then
given by Eq. (14) (Fannin et al. 1993).
seff ¼ sNsBðsN þ sBÞ ð13Þ
2pmeffseff ¼ 1 ð14Þ
Recent research optimized the heating efficiency by
tuning the MNPs size to match the total relaxation time
(stotal = sN ? sB) to the applied frequency (m = 12pstotal)
(Khandhar et al. 2011).
The strong dependence of the SAR on multiple magnetic
properties such as saturation magnetization and relaxation
time, physical parameters like size, shape and composition
can be tailored to enhance the heat dissipation and thus
lower the injected dose of SPMNPs in the tumor site.
Biomaterials for magnetic hyperthermia
To develop excellent candidates for magnetic hyperther-
mia, it is very important to review the recent advances and
limitations in the development of MNPs for magnetic
hyperthermia applications.
Superparamagnetic iron oxide nanoparticles (SPIONs)
are the most used MNPs for biomedical applications,
especially magnetic hyperthermia. They received consid-
erable attention due to their biocompatibility compared to
other magnetic materials such as cobalt and nickel (Tran
et al. 2012a, b). The high biocompatibility of IONPs is due
to well-controlled cell homeostasis by uptake, excretion
and storage (Chenga et al. 2005).
However, nickel and cobalt are susceptible to oxidation
and toxic, even though they exhibit a high magnetic
moment, because they are not essential elements to the
body like iron and thus accumulate in the body and cause
illness. It is worth noting that SPIONs may induce dermal
toxicity via their ability to be internalized and thereby
initiate oxidative stress leading to inflammation (Murray
et al. 2013).
IONPs become superparamagnetic at room temperature
when their radius is below about 15 nm (Kolhatkar et al.
2013), and aggregation is a common phenomenon among
SPIONs (Wu et al. 2015). Therefore, bare SPIONs are
coated against aggregation by either non-magnetic or
magnetic shell (Zenga et al. 2004). Usually, the type of
coatings has an impact on the heating efficiency of the core
through modifying the surface properties. Details on the
types of shells used to protect IONPs and their effect over
magnetic properties will be discussed.
Among iron oxides, magnetite (Fe3O4) and maghemite
(c-Fe2O3) are very popular candidates and have unique
magnetic properties suitable for biomedical applications.
Iron metal (Fe) has a higher magnetization than mag-
netite and maghemite. However, Fe is highly susceptible to
oxidation, which limits its use for biomedical applications.
Qiang et al. synthesize oxidative stable Fe-core MNPs
coated with iron oxide and having an increasing Ms from
about 80 emu/g (at the cluster size of 3 nm) to 200 emu/g
(at the size of 100 nm) (Qiang et al. 2006).
In general, MNPs are coated with a selected material to
enhance their colloidal stability and biocompatibility or to
offer them the capacity to functionalize the surface, like in
the case of a coating of silica (SiO2) (Rittikulsittichai et al.
2013). Furthermore, coating can be used to modify MNPs
surface to increase their Ms and consequently increase the
SAR.
Studies show that coating MNPs with non-magnetic
material, for example Fe3O4 coated with SiO2 (Larumbe
et al. 2012a, b), will reduce Ms (from 72 emu/g to 37 emu/
g) and hence SAR (from 1.5 ± 0.1 to 1.08 ± 0.04 W/g) as
compared to uncoated MNPs. The decrease in Ms was
attributed to the enhanced surface spin effects, and thus not
all the IONPs mass contribute to Ms. Furthermore, the
effective anisotropy constant ‘Keff’ increases due to the
strain and surface spin disorders created by SiO2 coating,
and the blocking temperature TB experiences similar vari-
ations since TB is defined as the product of the Keff and the
volume of the nanoparticles ‘V’ (Eq. 15) (Cos¸kun et al.
2010).
TB ¼ Keff  V
25  kB ð15Þ
Surface spin effect (or surface spin disorder) is the result
of the surface electrons engagement in the bond with the
coating material, which no longer participate in the mag-
netic super-exchange bonds between metal cations (ex-
ample: Fe–O–Fe), and thus reduce the coordination
between surface spins (Kodama et al. 1996).
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Fe3O4 NPs coated with SiO2 and functionalized with
propylamine groups showed higher magnetization satura-
tion (Ms & 42 emu/g) than uncoated Fe3O4
(Ms & 27 emu/g), where both were synthesized by ther-
mal decomposition in oleic acid (Woo et al. 2005). It seems
that the surface of Fe3O4 is magnetically more active in
Fe3O4 NPs coated with silica-propylamine than that of
uncoated Fe3O4 covered with oleic acid.
On the contrary, Fe3O4 NPs coated with silica-propy-
lamine showed slightly lower magnetization saturation
(Ms & 58 emu/g) than uncoated Fe3O4 (Ms & 60 emu/g)
(Yamaura et al. 2004), where Fe3O4 NPs were obtained by
co-precipitation in aqueous medium. The contradictory
results of these two studies suggest that the synthesis and
coating methods can be tailored to enhance the magnetic
properties of the MNPs.
Capping Co-MNPs with metallic shell (such as Cu or
Au) provides us a high tuning opportunity over the mag-
netic properties (for example, enhanced surface anisotropy
and higher blocking temperature), due to the bonding of the
d-orbital electrons of the core to the conduction band
orbitals of the capping layer (Luis et al. 2006). This sug-
gests that the surface anisotropy is mainly determined by
the electronic states of the core–shell metals and, therefore,
it could be tuned by choosing materials with appropriate
electronic band structures.
For hyperthermia applications, an SLP of 1000 W/g is
necessary at 100 kHz and 20 mT (human-compatible
conditions). By taking advantage of the exchange coupling
between a magnetically hard core (CoFe2O4) and soft shell
(Mn Fe2O4), MNPs exhibiting a significant enhancement in
SLP have been developed (Lee et al. 2011). Various
combinations of core–shell nanoparticles tuned Ms of the
single-component MNPs to achieve high SLP while
maintaining the superparamagnetism. For example
Zn0:4Co0:6Fe2O4 core and Zn0:4Mn0:6Fe2O4 shell MNPs
have an SLP of 3866 W/g and thus exhibit 1.7 times higher
SLP than that for CoFe2O4(core) MnFe2O4(shell) MNPs
(2274.12 W/g) and 34 times larger than that for commer-
cial Feridex Fe3O4 NPs (114 W/g).
Spherical Mn Fe2O4 SPMNPs show lower SLP of
411 W/g (r = 15 nm) when compared to that of Mn
Fe2O4(core) Co Fe2O4(shell) (r = 15 nm) where SLP is
about 3034 W/g (Noh et al. 2012). Clearly, core–shell
design has the advantage in achieving large SLP while
keeping the superparamagnetism of the nanoparticle. In the
same work, cubes of Co Fe2O4 coated with Zn0:4Fe2:6O4
showed a 4-fold increase in coercivity as compared to the
core alone. This increase is consequently followed by a
dramatically higher SAR for the shell-core MNPs
(10,600 W/g) when compared to that of MNPs composed
of just the core (4060 W/g).
Many efforts have been dedicated toward understanding
the relationship between the shape of MNPs and their
magnetic properties. Several studies showed that the Ms is
proportional to the volume of the particle (V) with the same
crystalline composition but different shape (Chou et al.
2009; Shevchenko et al. 2003), due to the decrease of the
surface-to-volume ratio and consequently surface spin
disorder. For example, considering MNPs having the same
unit size (d) (where ‘d’ corresponds to the side length for
nanocubes, the width for nanorods and the diameter for
nanospheres), the V of nanocube is higher than the V of
nanorod, and the V of nanosphere is lower than the V of
nanorod. Therefore, the same order of Ms is expected (Ms
of nanocube[Ms of nanorod[Ms of nanosphere).
A study on the effect of the shape of Fe3O4 NPs over its
saturation magnetization is done by Zhen et al. (Zhen et al.
2011). The authors observed a higher Ms for the cubic
shape (Ms = 40 emu/g) compared to the spherical shape
(Ms = 31 emu/g), where the volume of the cube is slightly
higher than that of the sphere (Vcube[Vsphere). They
attributed the lower magnetization of spherical Fe3O4 NPs
to their crystalline defect structure or greater degree of
oxidation and non-magnetic iron oxide (Fe2O3) content.
According to Noh et al. (2012), the cubic shape of
Zn0:4Fe2:6O4 has a higher Ms (165 emu/g) value than the
spherical shape (145 emu/g) with the same volume. In fact,
the surface of the cube shape has a smaller surface aniso-
tropy since its topology comprises low energy facets. As a
result, disordered magnetic spins in cubic NPs (4 %) are
lower than in spherical NPs (8 %).
However, in a study done by Montferrand et al. on
Fe3O4 NPs (Montferrand et al. 2013) Ms for the cubic
shape (40 emu/g) is lower than the spherical shape
(80 emu/g) of the same size. Unexpected Ms could be
related to size polydispersity and polymorphism detected in
TEM images.
Magnetic properties are also defined by the atomic state
of the elements, especially the number of unpaired valence
electrons. For example, Fe(III) have five unpaired electrons
and thus a moment of 5 9 1.73 = 8.65 Bohr magnetons.
Moreover, the distribution of ions in the structure is another
parameter responsible for the determination of the moment.
For example, in an inverse spinel structure of ferrites, the
magnetic moments of the cations in the octahedral sites are
aligned parallel to the magnetic field, and the ones in the
tetrahedral sites are antiparallel, leading to a decrease in the
net moment (Lee et al. 2006).
Hence, doping MNPs with cations is of great interest in
nanomedicine because it tailors the physical and magnetic
properties, without affecting its crystal structure, due to the
nature of the cation and its relative distribution in the
tetrahedral and octahedral sites (Fantechi et al. 2012).
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Lee et al. (2006) compared the crystal structure of four
spinel ferrites (M Fe2O4): MnFe2O4 (110 emu/g), Fe
Fe2O4 (101 emu/g), CoFe2O4 (99 emu/g), and NiFe2O4
MNPs (85 emu/g). MnFe2O4 had a mixed spinel structure,
where Mn2þ and Fe3þ occupied both octahedral and
tetrahedral sites, and an inverse spinel structure where
Mn2þ and Fe3þ occupied octahedral sites and only Fe3þ
occupied the tetrahedral sites.
The inclusion of Ni2þ in the ferrite spinel structure
(NixFe3xO4 with x = 0, 0.04, 0.06 and 0.11) has no
substantial change in the value of Ms, where Ni2þ occupy
Fe2þ octahedral sites (Larumbe et al. 2012a, b). Gabal et al.
examined the Zn2þ doped nickel ferrite (Ni1xZnxFe2O4;
0\ x\ 1) and noticed that the Ms increases by increasing
Zn doping levels up to 0.5 (Jalalya et al. 2010). This
behavior can be explained by the fact that magnetite
(Fe3O4), with a spinel structure, has Fe
3þ ions occupying
tetrahedral (inverse) sites and Fe2þ with Fe3þ ions residing
in the octahedral sites. During cation exchange Fe2þ in
octahedral site is replaced by Ni2þ and NiFe2O4 is formed.
Since the tetrahedral and octahedral sites are antiferro-
magnetically coupled, the net moment of Ni ferrite equals
the moment of octahedral site (Ni2þ, Fe3þ) minus the
moment of tetrahedral (Fe3þ). The inclusion of non-mag-
netic Zn2þ in NiFe2O4 substitutes Ni2þ then occupies a
tetrahedral site and force magnetic Fe3þ to migrate to
octahedral site and, as x increases. As a result, the net
moment increases due to the decrease in fraction of
moment of tetrahedral site and an increase in the moment
of octahedral sites (Jalalya et al. 2010).
FeCo MNPs usually exhibit high Ms values (122–
230 emu/g) compared with CoFe2O4 MNPs (Chaubey
et al. 2007), due to the absence of the non-magnetic oxygen
component (Zhang et al. 2012). However, the ease of
oxidation in the presence of air is the key issue for these
alloys (Zhang et al. 2012).
Palladium metal is a non-magnetic element, but tends to
order ferromagnetically when alloyed with a small amount
of magnetic transition metal impurities (such as Fe, Co and
Ni 3d metals) (Crangle and Scott 1965). A polarization of
Pd atom by a magnetic impurity is due to the hybridization
and exchange between 4d and 3d orbitals (Fig. 5) (Van
Acker et al. 1991).
The appearance of ferromagnetism can be explained by
the large density of states at the Fermi level (EF).
Paulus and Tucker (1995) proposed for the first time
PdCo seeds for thermal treatment of tumors. PdCo ther-
moseeds (typically rod shape where d = 1 mm and
L = 1–2 cm) are permanently implanted into the cancerous
tissue, and thus the patient can be scheduled for activation
of the thermoseeds at intervals of minimal thermotolerance
(Paulus and Tucker 1995). The authors developed a new
approach to treat prostate cancer, post-radiotherapy, using
these thermoseeds. During thermotherapy, PdCo rods heat
up when exposed to an alternative magnetic field (due to
eddy current) to a specific temperature (Curie temperature),
at which the alloy goes from being magnetic to non-mag-
netic, and ceases to heat up and it simply maintains the
Curie temperature as long as it remains in the magnetic
field (Paulus and Tucker 1995).
Deger et al. (2002) conducted a clinical study on the
treatment of patients with localized prostate cancer with a
magnetic hyperthermia, using self-regulating PdCo ther-
moseeds, after radiotherapy. During hyperthermia, PdCo
thermoseeds heating temperatures were between 42 and
46 C with a Curie temperature of 55 C. The initial
median prostate-specific antigen (PSA) value was 11.6 ng/
ml, and then decreased to 1.3 and 0.55 ng/ml after 12 and
24 months, respectively, after the therapy. Moreover, PdCo
seeds proved to be biocompatible and do not show major
complication during the treatment, and remain in the
prostate during follow up (Deger et al. 2002).
According to Brezovich and Meredith (1989), a heat
production rate of 200 mW/cm is adequate for most clinical
application. El-Sayed et al. calculate the power dissipated
from Pd89:2Co10:8,Pd73Ni27 and Cu29:6Ni70:4 ferromagnetic
seeds, having a rod shape with a diameter of 0.9 mm
diameter and a 5.5 cm length as function of temperature
(El-Sayed et al. 2007). At 20 C, the heating power of
Pd89:2Co10:8 was about 171 mW/g, and 150 mW/g for
Pd73Ni27. The Cu29:6Ni70:4 seed showed a much smaller
heating power of 80 mW/g. Therefore, Pd89:2Co10:8 seed
exhibited the highest heating power to treat localized
tumors compared with the other two alloys.
Iron based-MNPs have been widely studied for nano-
medicine (especially for cancer treatment) and palladium-
cobalt alloys have not received significant attention.
Although Pd and Co are toxic elements, PdCo alloy has a
higher stability and resistance to corrosion (Wataha et al.
1991) compared to Fe-based alloy (Arbab et al. 2005).
Moreover, the researches done over PdCo thermoseeds are
very promising and encouraging to develop new MNPs
candidates for thermotherapy made of PdCo alloys.
Fig. 5 Illustration of the covalent interaction between Fe 3d and Pd
4d orbitals (reproduced from Van Acker et al. 1991)
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Nanotoxicity of biomaterials
Considering the wide preclinical and clinical applications
of magnetic iron oxide NPs in nanomedicine, it is crucial to
understand the potential nanotoxicity associated with
exposure to these NPs and especially the physiological
effects produced by the surface coatings used for
functionality.
The work of Pisanic et al. (2007) showed that the
intracellular delivery of 0.15–15 mm of iron oxide (Fe2O3)
NPs may adversely affect cell function and results in a
dose-dependent diminishing viability and capacity of PC12
cells (rat pheochromocytoma cell line) to differentiate, in
response to nerve growth factor.
In fact, uncoated iron oxide NPs have a low solubility
that can lead to their precipitation and a high rate of
agglomeration under physiological conditions (Lei et al.
2013). Coating these NPs aims to stabilize their surfaces
against agglomeration and dissolution, and allows the
grafting of biomolecules (such as antibodies and drugs)
(Sadeghiani et al. 2005). However, the type of surface-
coating materials is important to determine the toxicity of
coated NPs.
The cytotoxic potential of iron oxide NPs with a range
of surface coatings has been extensively investigated.
Hilger et al. (2003) estimated the cytotoxic potential of
cationic/anionic coated magnetite (Fe3O4) nanoparticles by
measuring the succinate dehydrogenase activity in human
adenocarcinoma cells (BT-20). Cationic particles showed
to induce the strongest decrease in cell survival rates of
BT-20 cells (0 ± 0 after incubation for 72 h) for a con-
centration of 20 ng/cell. This is due to some strong elec-
trostatic bindings to cellular membranes. On the other
hand, Berry et al. (2003) found that dextran-coated iron
oxide NPs could induce cell death and reduce proliferation
of human fibroblasts during internalization. Significant
membrane disruptions were observed in fibroblasts cells,
including possible apoptosis and aberrations in cell mor-
phology, causing decreases in cells motility (Berry et al.
2004).
Recent studies show that Fe3O4 NPs can affect the
cellular functionality by altering the level of transferrin
receptor expression and can change the cellular prolifera-
tion capacity by altering the expression of cyclins and
cyclin-dependent kinases in cell cycle (Scha¨fer et al. 2007;
Huang et al. 2009). Moreover, researchers are finding
evidence that Fe3O4 NPs exposure can produce mutagenic
effects including: chromosomal aberrations, DNA strand
breakage, oxidative DNA damage and mutations (Koedrith
et al. 2014). Other research has reported that the excess of
iron exposure has been found to cause elevated ROS
generation through the Fenton reaction, resulting in
oxidative stress that damages DNA, lipids and proteins,
consequently resulting in carcinogenesis (Toyokuni 1996).
These findings confirm previous reports that the presence
of intracellular Fe3O4 nanoparticle constructs can result in
significant changes in cell behavior and viability
(Buyukhatipoglu and Clyne 2011).
Upon administration into tumor tissue, MNPs interact
with blood components, where thousands of biomolecules
compete for limited space on an NP surface (Cedervall
et al. 2007), due to van der Waal’s interactions, electro-
static interactions, hydrogen bonding and/or hydrophobic
interactions (Hlady and Buijs 1996). As a result, MNPs
acquire a dynamic exchange plasma proteins layer, so-
called ‘corona’ (Cedervall et al. 2007), in which competi-
tive displacement of earlier adsorbed proteins by other
proteins with stronger binding affinities takes place and is
referred to as ‘Vroman Effect’ (Hirsh et al. 2013). Thus, the
identity, organization and residence time of these proteins
determine the way cells interact with NPs (Cedervall et al.
2007). Moreover, the adsorbed proteins identity and their
total amount showed to be strongly dependent on the par-
ticle surface chemistry (like surface composition, charge,
topography and area) (Hlady and Buijs 1996).
Studies show that plasma proteins, including
immunoglobulins and complement proteins, once adsorbed
to NPs surfaces it target the particles as pathogens for
clearance (called ‘opsonization’) by the reticulo-endothe-
lial system and mononuclear phagocytic system (Ehren-
berg et al. 2009). In fact, the immune system may
recognize the proteins as native or as foreign pathogen
depending on whether the proteins bind or not to immune
cells receptors. Following proteins adsorption, platelets
cells adhesion and activation on NPs may occur via inter-
action of adhesion receptors with the adsorbed blood pro-
teins such as fibrinogen, fibronectin, vitronectin, and the
von Willebrand factor (Nygren et al. 1995; Elam and
Nygren 1992). As a result, inflammatory cells (primary
polymorphonuclear leukocytes) migrate from the blood
toward the NPs, triggered by chemoattractants released
from activated cells (Franz et al. 2011). Inflammatory cells’
adsorption over the protein-coated NPs surface, due to
protein ligands of integrins, leads to an acute or chronic
inflammation (Nimeri et al. 2002).
The concept of inert biomaterials points out the need of
strategies for improving implant integration, to avoid for-
eign body reactions. It was shown that when macrophages
are cultured on surface-modified polymers displaying
hydrophobic, hydrophilic and/or ionic chemistries, they
change their protein expression profiles and cytokine/che-
mokine responses (Dinnes et al. 2007). Consequently,
current studies in the design of such biomaterials include
passive modulation of the surface chemistry, to limit
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immune responses. For example, polyethylene glycol
(PEG)-modified surface reduces protein adsorption due to
its sterically hindered and hydrophilic coating (Torchilin
and Papisov 1994), and this leads to more blood circulation
of PEG-coated NPs. On the other side, functionalization of
the surface with bioactive molecule such as adhesion sites
(Kao and Lee 2001), anti-inflammatory drugs (Franchi-
mont et al. 2002) and growth factors (Barrientos et al.
2008) is also a very interesting strategy for modulating or
suppressing inflammatory responses.
MNPs can induce toxicity, not only by activating cells in
a direct way as discussed above, but also indirectly by
excessive tissue accumulation of free metal ions (Weir
et al. 1984). It was shown that reactive oxygen species
(ROS) are generated by the cells as a result of leached ions
after exposure to an acidic environment, such as lysosomes
(pH 4.5) (Albrecht et al. 2004). In general, most cells can
tolerate a certain amount of ROS, whereas higher levels of
ROS persist over a longer time and may result in cell
damage and subsequent induction of toxic effects (Wang
et al. 2007). Since the toxicity of the NPs is affected by the
level of induced ROS, the surface must be stable against
degradation to limit the quantity of free metal ions.
Potential (Eh)-pH diagram or Pourbaix diagram is
essential to investigate the thermodynamic of material cor-
rosion, by monitoring the regions of potential and pH where
the metal is: unreacted (region of immunity), protected by a
surface film of an oxide or a hydroxide (region of passivity)
or dissolved (region of corrosion) (McCafferty 2010). Fig-
ure 6 shows the Pourbaix diagram for both iron and palla-
dium elements in water containing fluoride ions (Villican˜a
et al. 2007). According to the diagram, iron will corrode and
produce Fe(II) and/or Fe(III) at potential zero and at pH
below 6, whereas palladium remains unreacted under these
conditions. This difference in stability is due to the higher
reactivity of iron towards oxidation (E

FeðIIÞ=Fe = -0.44 V;
E

FeðIIIÞ=Fe = -0.04 V), compared with palladium
(E

PdðIIÞ=Pd = ?0.915 V). Moreover, iron forms a porous
oxide layer when exposed to water or air (Hill and Holman
2000), and consequently anodic (iron)/cathodic (iron oxide)
sites created at the surface trigger the process of corrosion.
The reactivity of iron towards oxidation reveals the
toxicity of uncoated IONPs (Pisanic et al. 2007), and
suggests more study into the biocompatibility of the coat-
ings on the long term (Hilger et al. 2003). The most
important source of toxicity of IONPs is described by
‘Fenton’ and ‘Fenton like’ reactions (Eqs. (16) and (17a,
17b), respectively) (Salgado et al. 2013), in which the
Fe(II) or Fe(III) reacts with H2O2 to produce ROS species.
Fe IIð Þ þ H2O2 ! Fe(III)þ HO þ HO
k ¼ 76M1s1 ð16Þ
Fe IIIð Þ þ H2O2 ! Fe(II)þ HO2 þ Hþ ð17aÞ
Fe IIIð Þ þ HO2 ! Fe(II)þ O2 þ Hþ
k ¼ 0:01 M1s1 ð17bÞ
Free ROS species exhibit a lack of specificity with
which they react (Pryor 1976), and this makes the study of
the oxidative mechanism in the toxicity of iron ions very
complex (Stohs and Bagchi 1995). However, ROS inter-
actions with biological components have been classified
into three types of reactions: electron transfer, radical
addition and atom abstraction, and identified to cause cell
damage (Moslen and Smith 1992).
The toxicity of Pd, Co pure metal and Pd43Co57 alloy
was tested in vitro for dental casting (Kawata et al. 1981).
It was shown that the cells multiply in the presence of Pd as
much as those for the control, and keep their natural form.
Whereas in the presence of Co, the cells degenerate with
time and approaches zero at 72 h of incubation due to the
cytoplasmic shrinkage and blister formation. On the other
hand, the binary alloy Pd43Co57 enhances the cells growth
and morphology compared with pure Co, showing a
monotonically increase of cell multiplication like the
control. These results indicate that the toxicity of Co may
be avoided when alloyed with Pd.
The corrosion of the binary alloy Pd80;8Co19;2 in syn-
thetic saliva (Goehlich and Marek 1990) produces a
selective dissolution of the less noble components ‘Co’ on
the surface of the alloy, leaving a Pd-enriched layer on the
surface. The results of corrosion are in accordance with
that of toxicity, the safety of a biomaterial largely depen-
dent on its corrosion resistance. Therefore, pure palladium
is non-toxic due to the low dissolution rate of palladium
ions (Wataha and Hanks 1996), while pure Co is not
stable and thus releases toxic cobalt ions.
Fig. 6 Pourbaix diagram showing iron and palladium species and
water stability region (reproduced from Villican˜a et al. 2007)
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Despite belonging to essential trace elements of the
human body, the accumulation of cobalt ions is genotoxic
and may cause induce necrosis with inflammatory response
(Donaldsaon and Beyersmann 2005). The oral median
lethal dose (LD50) for soluble Co salts has been estimated
to be between 150 and 500 mg/kg body weight (Donald-
saon and Beyersmann 2005). Further, very low doses of Pd
are sufficient to cause allergic reactions in susceptible
individuals (Kielhorn et al. 2002). Oral LD50 of palladium
oxide is about 4.9 g/kg body weight (Nordberg et al. 2014).
Also high concentrations of Pd ions are capable of eliciting
a series of cytotoxic effects (Kielhorn et al. 2002).
Electrochemical corrosion test and immersion test were
performed at 37 C for Pd93:85Co6:15 alloy sample (with a
density of 11.4 g/cm3) in mammalian Ringer’s solution
(Paulus et al. 1997). The tests results showed a long-term
corrosion rate of 7.7 9 108 lm/year, and a release of
0.7 lg/l of Pd(II) with 1.8 lg/l of Co(II) per year, indi-
cating a significantly high corrosion resistance of PdCo
compared with standard surgical implants (0.04 lm/year)
(Paulus et al. 1997).
According to the phase diagram of PdCo alloy (Fig. 7),
a single phase solid solution of substitutional Co atoms in a
Pd lattice is formed when the atomic percentage of Pd is
higher than 53 %. Consequently, the corrosion behavior of
the PdCo alloy will be similar to that of pure Pd. In fact,
palladium remains unreacted at normal pH or even acidic
environment, as stated in Pourbaix diagram (Fig. 6). Pure
palladium corrodes only in extremely acidic medium,
which is unlikely to occur in biological media. The selec-
tive dissolution of Co near or at the surface on the long-
term is possible (Paulus et al. 1997), and as a result Co-
depleted layer is formed. The alloy is then likely to exhibit
passivation behavior of pure palladium. An additional
dissolution of cobalt may occur by volume diffusion of
these less noble atoms to the surface (Pickering and
Wagner 1967).
Alloying Pd and Co not only induces ferromagnetism in
Pd atoms but also enhances the corrosion resistance of Co
atoms, which makes this alloy a good candidate for
biomedical application.
Very recently using magnetic nanoparticles for
enhancing the effectiveness of ultrasonic was shown
(Jo´zefczak et al. 2016). It was indicated that the effec-
tiveness of ultrasound (US) for medical applications can be
significantly improved by using sonosensitizers like mag-
netic nanoparticles with mean sizes of 10–300 nm. These
NPs can be more effectively heated because of additional
attenuation and scattering of US. Accordingly, this can
enhance the thermal effect of ultrasound (US) on the tissue
by increasing US absorption. The other interesting aspect
using magnetic NPs is that they are able to produce heat in
the alternating magnetic field (magnetic hyperthermia).
This is particularly important because it introduces syner-
getic application of ultrasonic and magnetic hyperthermia
which can lead to a promising treatment modality. In
particular, it was found that in the samples with magnetic
nanoparticles, the synergetic action of ultrasounds and
magnetic field allowed achieving better heating effect in
comparison to the heating by either US or alternating
magnetic field (AMF) alone. This synergistic effect was
confirmed by specific absorption rate (SAR) values. The
following SAR values were, respectively, obtained: 66
mW/g for magnetic hyperthermia, 175 mW/g for ultrasonic
hyperthermia, and 375 mW/g for both methods applied
simultaneously. This opens the ways to future potential
investigations of better utilization of NPs and ultrasound
for stand-alone magnetic hyperthermia therapy
applications.
Conclusions
Magnetic NPs are frequently employed in biomedical
research as drug delivery systems and/or magnetic reso-
nance contrast agents. Nevertheless, the safety issues of
these particles have not been completely solved because it
is difficult to compare the cytotoxicity data since the toxic
effects of NPs are influenced by many parameters (such as
size distribution, surface coating, magnetic properties, etc.)
(Auffan et al. 2006). Also, numerous studies showed con-
tradicting findings since different cell types will interact
with the same particle in different ways (Barua and Rege
2009). Moreover, the lack of coherence between various
research activities for establishing priorities among the
research needs is one reason why a toxicological profile of
these particles has not yet been well documented in the
literature. Therefore, along with the expanding applications
Fig. 7 Phase diagram of PdCo system obtained from FactSage
software (Bale et al. 2002)
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of NPs and the growing numbers of consumer products
containing NPs, the release of these substances into the
environment is expected, and the impact of these materials
is increasing significantly (Zhu et al. 2012).
In this study, we have reviewed the basics of magnetic
properties and nanotoxicity of NPs for magnetic hyper-
thermia. Also, recent advances on the most used MNPs for
biomedical application were discussed. From this study, it
can be seen that despite its corrosion problem, iron oxide
NPs have received considerable attention. However, new
candidates such as PdCo NPs may have a great potential
for magnetic hyperthermia due to their high corrosion
resistance and good ferromagnetic behavior.
Some challenges need to be addressed on the design of
novel NPs, which must meet the demands of a particular
application. The elaboration of methods must be also sig-
nificantly improved to assess the toxicity of NPs, such as
reference biomaterials for safety testing. Synergetic
approaches combining magnetic and ultrasounds properties
must be also more investigated to improve the applicability
of magnetic NPs for magnetic hyperthermia therapy.
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